FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to the new method for the preparation of indolo[1',7':1,2,3]pyrrolo[3',4':6,7]azepino[4,5-b]indole-1,3(2H,10H)-dione, which is the starting material for the preparation of the potential antitumor preparation of 6-[(4-methyl-1-1-piperazinyl)methyl]-indolo[1',7':1,2,3]pyrrolo[3',4':6,7]azepino[4,5-6]indole-1,3(2H,10H)-dione). Method includes the steps of introducing the protecting group along the indole nitrogen atom, the subsequent dehydrogenation step under the action of 2,3-dichloro-5,6-dicyanobenzoquinone, and the step of protective group removal.
.
EFFECT: claimed method allows to increase the yield of the final product more than twice as compared with the known method.
1 cl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
PIM1-KINASE INHIBITOR 6-[(4-METHYL-I-1-PIPERAZINYL)METHYL]-INDOLO[1',7':1,2,3]PYRROLO[3',4':6,7]AZEPINO[4,5-b]INDOLE-1,3(2H, 10H)-DIONE, METHOD FOR PREPARING AND USING IT | 2011 |
|
RU2466132C1 |
2-R-6-R-5-ARYL-PYRROLE[3,4-c]CARBAZOLE-1,3(2H,6H)-DIONE SYNTHESIS METHOD | 2009 |
|
RU2404983C1 |
AZAINDOL DERIVATIVES AS FACTOR Xa INHIBITORS | 2004 |
|
RU2330853C2 |
PHARMACEUTICAL COMPOSITION BASED ON 6-[(4-METHYL-1-1-PIPERAZINYL)METHYL]-INDOLO[1',7':1,2,3]PYRROLO[3',4':6,7]AZEPINO[4,5-b]INDOLE-1,3(2H,10 H)-DIONE AS ANTI-TUMOUR MEDICATION | 2013 |
|
RU2523387C1 |
MEDICINAL AGENT BASED ON 4-SUBSTITUTED 3(3-DIALKYLAMINOMETHYL-INDOL-1-YL)MALEIMIDE DERIVATIVES | 2006 |
|
RU2388759C2 |
INDANONE DERIVATIVE, ITS PHARMACEUTICALLY ACCEPTABLE SALT OR ENANTIOMER, METHOD FOR PRODUCING IT AND PHARMACEUTICAL COMPOSITION CONTAINING IT AND APPLICABLE FOR PREVENTING OR TREATING VIRAL DISEASE | 2012 |
|
RU2574591C2 |
CAMPOTECIN COMPOUNDS, METHODS OF PREPARATION THEREOF, INTERMEDIATES, AND THERAPEUTIC COMPOSITIONS | 1996 |
|
RU2164515C2 |
METHOD FOR PRODUCING 4-AROYL-1-(2-HYDROXYARYL)-5-(1H-INDOL-3-YL)-1,3-DIHYDRO-2H-PYRROLE-2,3-DIONES WITH ANTIMICROBIAL ACTIVITY | 2023 |
|
RU2806040C1 |
SPIROCYCLIC NITRILES AS PROTEASE INHIBITORS | 2012 |
|
RU2621695C2 |
COMPOSITIONS AND METHODS OF TREATING CANCER | 2006 |
|
RU2409579C2 |
Authors
Dates
2018-03-21—Published
2017-05-24—Filed